These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15233279)

  • 1. A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT.
    Ota T; Shinotoh H; Fukushi K; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Tanaka N; Sato K; Shiraishi T; Tanada S; Arai H; Irie T
    Ann Nucl Med; 2004 May; 18(3):187-93. PubMed ID: 15233279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.
    Tanaka N; Fukushi K; Shinotoh H; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):295-306. PubMed ID: 11295884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
    Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
    Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
    J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
    Okamura N; Shinkawa M; Arai H; Matsui T; Nakajo K; Maruyama M; Hu XS; Sasaki H
    Nihon Ronen Igakkai Zasshi; 2000 Dec; 37(12):974-8. PubMed ID: 11201187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
    Hirano S; Shinotoh H; Shimada H; Ota T; Sato K; Tanaka N; Zhang MR; Higuchi M; Fukushi K; Irie T; Kuwabara S; Suhara T
    J Alzheimers Dis; 2018; 62(4):1539-1548. PubMed ID: 29562505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein synthesis in the posterior cingulate cortex in Alzheimer's disease.
    Yoshida T; Kazui H; Tokunaga H; Kito Y; Kubo Y; Kimura N; Morihara T; Shimosegawa E; Hatazawa J; Takeda M
    Psychogeriatrics; 2011 Mar; 11(1):40-5. PubMed ID: 21447108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.
    Richter N; Nellessen N; Dronse J; Dillen K; Jacobs HIL; Langen KJ; Dietlein M; Kracht L; Neumaier B; Fink GR; Kukolja J; Onur OA
    Neuroimage Clin; 2019; 24():101978. PubMed ID: 31422337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study.
    Saito N; Nakagawara J; Nakamura H; Teramoto A
    Ann Nucl Med; 2004 Jun; 18(4):323-31. PubMed ID: 15359926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Database of normal human cerebral blood flow measured by SPECT: II. Quantification of I-123-IMP studies with ARG method and effects of partial volume correction.
    Inoue K; Ito H; Shidahara M; Goto R; Kinomura S; Sato K; Taki Y; Okada K; Kaneta T; Fukuda H
    Ann Nucl Med; 2006 Feb; 20(2):139-46. PubMed ID: 16615423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Error analysis of measured cerebral vascular response to acetazolamide stress by I-123-IMP autoradiographic method with single photon emission computed tomography: errors due to distribution volume of I-123-IMP.
    Ito H; Inoue K; Goto R; Kinomura S; Sato T; Kaneta T; Sato K; Fukuda H
    Ann Nucl Med; 2004 May; 18(3):221-6. PubMed ID: 15233283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting the most relevant brain regions to discriminate Alzheimer's disease patients from healthy controls using multiple kernel learning: A comparison across functional and structural imaging modalities and atlases.
    Rondina JM; Ferreira LK; de Souza Duran FL; Kubo R; Ono CR; Leite CC; Smid J; Nitrini R; Buchpiguel CA; Busatto GF
    Neuroimage Clin; 2018; 17():628-641. PubMed ID: 29234599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson's disease: objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT].
    Sakai T; Kuzuhara S
    No To Shinkei; 2006 Jan; 58(1):29-37. PubMed ID: 16482919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.
    Ogasawara K; Ito H; Sasoh M; Okuguchi T; Kobayashi M; Yukawa H; Terasaki K; Ogawa A
    J Nucl Med; 2003 Apr; 44(4):520-5. PubMed ID: 12679394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison study between FDG-PET and IMP-SPECT for diagnosing Alzheimer's disease using 3D-SSP analysis in the same patients.
    Nihashi T; Yatsuya H; Hayasaka K; Kato R; Kawatsu S; Arahata Y; Iwai K; Takeda A; Washimi Y; Yoshimura K; Mizuno K; Kato T; Naganawa S; Ito K
    Radiat Med; 2007 Jul; 25(6):255-62. PubMed ID: 17634878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry.
    Ito H; Inoue K; Goto R; Kinomura S; Taki Y; Okada K; Sato K; Sato T; Kanno I; Fukuda H
    Ann Nucl Med; 2006 Feb; 20(2):131-8. PubMed ID: 16615422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease.
    Kawabata K; Tachibana H; Sugita M; Fukuchi M
    Clin Nucl Med; 1993 Apr; 18(4):329-36. PubMed ID: 8482030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
    Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
    Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stepwise analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer's type].
    Kumakura Y; Momose T; Oku S; Ohtake T; Nishikawa J; Ohtomo K
    Kaku Igaku; 1998 Nov; 35(9):843-8. PubMed ID: 9916400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.